Rezvilutamide
Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.
Product Specifications
CAS Number
1572045-62-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
479.47
Molecular Formula
C22H20F3N3O4S
Notes
Research use only, not for human use.
Receptor
Androgen Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC201085L2V 200 µL
NSE (ENO2) (NM_001975) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS1293221-01 0.02 mg (E-Coli)
Recombinant Chromohalobacter salexigens Mannonate dehydratase (uxuA)
Sign In for Pricing
View Details MBS1293221-02 0.02 mg (Yeast)
Recombinant Chromohalobacter salexigens Mannonate dehydratase (uxuA)
Sign In for Pricing
View Details MBS1293221-03 0.1 mg (E-Coli)
Recombinant Chromohalobacter salexigens Mannonate dehydratase (uxuA)
Sign In for Pricing
View Details MBS1293221-04 0.1 mg (Yeast)
Recombinant Chromohalobacter salexigens Mannonate dehydratase (uxuA)
Sign In for Pricing
View Details MBS1293221-05 0.02 mg (Baculovirus)
Recombinant Chromohalobacter salexigens Mannonate dehydratase (uxuA)
Sign In for Pricing
View Details